IPO Boutique

Eyenovia, Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...



For IPO Boutique's "scale of 1 to 5" BUY rating on Eyenovia, Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Eyenovia, Inc.EYEN -
NASDAQ
$10.00-$12.00 $10.00 $10.002.73 million1/25/2018
Ladenburg Thalmann, Roth Capital Partners
Co-Manager(s):
Health Care
Filing(s):

Filed 2017-12-19
Terms Added 2018-01-09
Final Prospectus 2018-01-25



Eyenovia, Inc. Quote & Chart - Click for current quote - EYEN

About Eyenovia, Inc. (adapted from Eyenovia, Inc. prospectus):
They are a clinical stage biopharmaceutical company developing a pipeline of ophthalmology products utilizing their patented piezo-print technology to deliver micro-doses of active pharmaceutical ingredients, or micro-therapeutics, topically to the eye.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "EYEN" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved